Advancing retinal disease research by unraveling underlying molecular mechanisms and developing cost-effective gene therapies using mRNA and nanoparticles.
Lisboa, Portugal
Joined March 2021
- Tweets78
- Following111
- Followers188
- Likes361
We showcased ongoing research on gene therapies for inherited retinal diseases at two international conferences.
🗣️Miguel Seabra gave a talk at #CRS2026
📃Divya Pidishetty presented a poster at #FASEB2026
Thanks to #Retina4Future for supporting Divya with a travel grant.
Can non-viral mRNA delivery offer an efficient and safe alternative to viral gene therapy for inherited blindness? 🧬👁️
Read our latest paper to learn more: cell.com/molecular-therapy-f…
We thank @ChampalimaudF and @curechm for their support.
We’re proud to share that Cláudia Carvalho has been awarded a Doctoral INPhINIT Fellowship by @FundlaCaixa 🎓
Cláudia will work on precision genome editing for inherited retinal diseases using prime editing and non-viral mRNA delivery.
Seabra Lab retweeted
Choroideremia Research Foundation Announces Six New Global Grants to Accelerate Vision Science
#CureCHM #VisionResearch #CRF
einpresswire.com/article/819…
We are happy to share our latest publication!
mdpi.com/2076-3921/14/5/596
#benbedphar
#agerelatedmaculardegeneration
#retinaresearch
#eyeresearch
🌟 New Year, New Website! 🌟
We’re excited to kick off 2025 with a fresh start – the Ocular Low-Cost Gene Therapy Lab website is now live! Explore our projects, meet the team, stay updated with lab news, and check out our publications. Visit us at sites.google.com/research.fc…
Miguel Seabra will be speaking at the 4th mRNA-Based Therapeutics Summit Europe (28th-30th Jan 2025, Frankfurt, Germany)! Don’t miss this opportunity to explore the latest advances in mRNA therapeutics. Read more: ter.li/welq6g
#mRNA #GeneTherapy
Miguel Seabra won the NOVA Research Impact Narratives Challenge 2024! 🏆
His narrative, "Twenty years from Gene Identification to Therapeutic Intervention," showcases over two decades of pioneering work in gene therapy for retinal diseases. Read more: unl.pt/wp-content/uploads/20…
Seabra Lab retweeted
Happy to present our last research work on Ocular Gene Therapy at #ARVO2024, Seattle, WA! @MSeabraLab
Thanks to @ChampalimaudF @curechm for their funding support.
#Choroideremia #Inheritedretinaldiseases
Excited to share our latest research on isogenic stem cell models for Choroideremia, featured on the cover of Stem Cells and Development! 🌱🧬 Discover their potential for studying RPE degeneration mechanisms. Read the full paper: doi.org/10.1089/scd.2024.010… #ChoroideremiaResearch
More exciting news! Last week, Miguel Seabra was presented with a Career Award by the Portuguese Biochemical Society, during the XXII National Congress of Biochemistry at the University of Aveiro (Portugal).
Cheers to Miguel! 🎉
Our Group Leader, Miguel Seabra, has been distinguished with the European Society for Pigment Cell Research (ESPCR) Award at the 25th annual meeting in Marseille. This honor recognizes his significant contributions to skin pigmentation research.
Congratulations, Miguel! 👏
Seabra Lab retweeted
ONLINE NOW: Toward low-cost gene therapy: mRNA-based therapeutics for treatment of inherited retinal diseases dlvr.it/SzgyVm
Seabra Lab retweeted
France Choroïdérémie Symposium 2024 welcoming 🤩 In this photo Eric Hartman from CRF, Dr. Miguel Seabra @MSeabraLab & the van Renselaar Family.

Seabra Lab retweeted
France #Choroideremia symposium. Thank you to all the brilliant minds from all over the world discussing CHM. Taking another step forward 🙏🏻🙏🏻@sharmaruchi29 @JKJolly4 @Vision_INM @elfridedebaere @MaliaEdwardsLab @MariyaMoosajee @MiguelSeabra6 @eyeMacLaren @rharbottle @mluisosca
ALT Q&A researchers are answering questions
We are very happy and thankful with this award!
Throssell-Hillier #Choroidermia award winners announced!
Congratulations to Dr.Miguel Seabra Dr.Pedro Antas, Portugal: CRISPR-Based Gene Editing for CHM. @MiguelSeabra6
@MSeabraLab einpresswire.com/article/623…
A não perder
.@TenreiroSandra da @nova_medschool está a desenvolver modelos de retina em laboratório que podem ser usados para estudar os mecanismos moleculares que levam ao desenvolvimento da retinopatia diabética.
buff.ly/3Js6Efw
#90SegundosCiência
Seabra Lab retweeted
📍Applications for the 7th Edition of NBR (NOVA Biomedical Research) start on March 15!
Our #MSc programme will equip you with the core skills for an outstanding career in #Biomedical research.
📅 Deadline for applications: 15.03-30.04.2023
More info 👇
nms.unl.pt/nbr
Seabra Lab retweeted
LVPEI recognised as a top global institute
#HappyToShare #recognition #Ophthalmology #Healthcare #LVPEI #SoThatAllMaySee
Today is #rareDiseaseday! We want to express out support for all patients and families who are affected by rare diseases.
In our Lab, we are dedicated to study #choroideremia, a rare chorioretinal dystrophy that causes vision loss.
@curechm
@ChampalimaudF
@nova_medschool
